Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression
Authors:
Open Access
- 21 December 2018
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 38 (6)
Abstract
In view of the high incidence of gastric cancer and the functions of hypoxia-inducible factor 1α (HIF-1α), our study aimed to investigate the functionality of HIF-1α in gastric cancer, and to explore the diagnostic and prognostic values of HIF-1α for this disease. Expression of HIF-1α in tumor tissues and adjacent healthy tissues as well as serum collected from both gastric cancer patients and normal healthy controls was detected by qRT-PCR. Survival analysis was performed using Kaplan–Meier method. HIF-1α siRNA silencing cell lines were established. Effects of HIF-1α siRNA silencing as well as PI3K activator sc3036 on proliferation, migration, and invasion of gastric cancer cells were detected by Cell counting kit (CCK-8) assay, and Transwell migration and invasion assay. Effects of HIF-1α siRNA silencing on AKT and VEGF were detected by Western blot. Expression of HIF-1α was significantly down-regulated in tumor tissues than in adjacent healthy tissues in most gastric cancer patients. Serum levels of HIF-1α were also higher in gastric cancer patients than in normal healthy people. Serum HIF-1α showed promising diagnostic and prognostic values for gastric cancer. HIF-1α siRNA silencing inhibited the proliferation, migration, and invasion of gastric cancer cells, while PI3K activator sc3036 treatment reduced those inhibitory effects. Down-regulation of HIF-1α can inhibit the proliferation, migration, and invasion of gastric cancer possibly by inhibiting PI3K/AKT pathway and VEGF expression.Keywords
This publication has 21 references indexed in Scilit:
- Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and PreventionCancer Epidemiology, Biomarkers & Prevention, 2014
- Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasionTumor Biology, 2014
- Association of homocysteine with global DNA methylation in vegetarian Indian pregnant women and neonatal birth anthropometricsThe Journal of Maternal-Fetal & Neonatal Medicine, 2014
- HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancerInternational Journal of Oncology, 2013
- VEGF, HIF-1α Expression and MVD as an Angiogenic Network in Familial Breast CancerPLOS ONE, 2013
- Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheresMolecular Cancer, 2010
- Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast CancerClinical Cancer Research, 2006
- Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesisCancer Cell, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Assignment of the Hypoxia-Inducible Factor 1α Gene to a Region of Conserved Synteny on Mouse Chromosome 12 and Human Chromosome 14qGenomics, 1996